Skip to content

Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan

A Randomized, Open-Label, Crossover Study Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07429201
Enrollment
60
Registered
2026-02-24
Start date
2026-02-11
Completion date
2026-03-06
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Intake, Hydration Status

Keywords

Ramadan, iftar, beverage, fluid intake, feelings of well being, hydration, fasting, Saudi Arabia

Brief summary

The purpose of this study is to explore the effects of breaking the fast (iftar) during Ramadan with different beverages on dietary and beverage intake patterns and related measurements during the hours after iftar and into the next morning, as well as participants' self-reported feelings such as thirst, mood, and overall wellbeing.

Interventions

OTHERWitnessed ad libitum electrolyte-carbohydrate beverage intake over 120 minutes

Participants will consume the study electrolyte-carbohydrate beverage ad libitum over a 120-minute period following Iftar under supervised conditions. No other foods or beverages will be permitted during the first 120 minutes.

OTHERWitnessed ad libitum water intake over 120 minutes

Participants will consume water ad libitum over a 120-minute period following Iftar under supervised conditions. No other foods or beverages will be permitted during the first 120 minutes.

Sponsors

PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy Muslim adults aged 18-50 years who are observing Ramadan fasting. 2. Able and willing to provide written informed consent. 3. Able to speak, read, and understand Arabic or English sufficiently to comply with study procedures. 4. Willing and able to consume the electrolyte-carbohydrate (EC) beverage and water during study visits. 5. Demonstrates product acceptability during screening, defined as overall liking (OL) score ≥ 6 following consumption of a 50 mL sample of the EC beverage (9-point hedonic scale). 6. Self-reported as generally healthy with no known condition that would interfere with participation. 7. Able to comply with study procedures and attend two on-site intervention visits. 8. Willing and able to maintain usual daytime sleep patterns during the intervention period (i.e., avoid intentional major changes to sleep schedule) from 48 hours prior to each intervention visit until the following morning assessment.

Exclusion criteria

1. Any medical condition or medication use known to affect fluid balance/hydration status, including but not limited to diuretics, laxatives, weight-loss medications. 2. History of clinically significant cardiovascular, renal, endocrine, or metabolic disease. 3. Pregnant or breastfeeding (lactating) females, or females who plan to become pregnant during the study period. 4. Engagement in heavy/vigorous exercise within 24 hours prior to any study visit. 5. Participation in any PepsiCo-sponsored clinical trial within the previous 6 months. 6. Participation in any other interventional clinical trial within the previous 30 days.

Design outcomes

Primary

MeasureTime frameDescription
To compare post-fast fluid intake when breaking the fast with an Electrolyte-Carbohydrate beverage versus waterFrom iftar to 120 minutesTotal volume consumed in milliliters

Secondary

MeasureTime frameDescription
To characterize habitual fluid intake patterns before Ramadan using 24-hour dietary recall24 hour period prior to Ramadan fastingMeasured for usual non-fasting day
To characterize habitual fluid intake patterns during Ramadan using 24-hour dietary recall24 hour period during Ramadan fastingMeasured for a usual fasting day

Countries

Saudi Arabia

Contacts

PRINCIPAL_INVESTIGATORSalah Fouad, MD

Safa Pioneer Clinic, Jeddah Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026